Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead

AN

AnalystConsensusTarget

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

06 Aug 24

Updated

16 Dec 25

Views

210

n/a

n/a

AnalystConsensusTarget's Fair Value

n/a

1Y

0.3%

7D

-0.7%

Loading

1Y

0.3%

7D

-0.7%

You can edit this narrative until Dec 17 10:10 AM. Then, changes will post as Updates.

Author's Valuation

US$92.9312.2% undervalued

AnalystConsensusTarget Fair Value

Shared on 16 Dec 25

Fair value Decreased 0.077%

MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power

Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.

Shared on 07 Nov 25

Fair value Decreased 0.36%

MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements

Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.

Shared on 24 Oct 25

Fair value Increased 0.36%

Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.

Shared on 09 Oct 25

Fair value Increased 1.24%

Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.

Shared on 04 Sep 25

With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.

Shared on 07 May 25

Fair value Decreased 7.36%

Shared on 30 Apr 25

Fair value Increased 4.50%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 16 Apr 25

Fair value Decreased 5.94%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

Fair value Increased 0.30%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 5.07%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

Fair value Increased 0.45%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 10 Mar 25

Fair value Increased 1.22%

AnalystConsensusTarget has increased discount rate from 7.1% to 7.9%.

AnalystConsensusTarget Fair Value

US$92.93

12.2% undervalued

Future estimation in

Growth p.a.

Growth p.a.

%

Decrease

Increase

Current revenue growth rate

3.53%

Insurance revenue growth rate

0.27%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

%

0

Decrease

Increase

Current discount rate

7.69%

Calculation

US$6.49b

Earnings '28

x

10.66x

PE Ratio '28

=

US$69.15b

Market Cap '28

US$69.15b

Market Cap '28

/

596.18m

No. shares '28

=

US$115.99

Share Price '28

US$115.99 Share Price '28

Discounted to 2025 @ 7.68% p.a.

=

US$92.90

Fair Value '25